Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio
Nuklearmedizin - NuclearMedicine · 01.08.2024 · 63 (04) · 259-266
DOI: 10.1055/a-2287-2051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.08.2024. Verfasst von Julia Katharina Vogt und 3 weiteren Autor:innen. Beteiligte Einrichtung: GB Sicherheit und Compliance, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Ventilation-Perfusion Ratio. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: GE Healthcare.
Abstract (Originalsprache)
Aim
The aim of this study is to investigate whether computer-aided, semi-automated 3D lung lobe quantification can support decision-making on PE diagnosis based on the ventilation-perfusion ratio in clinical practice.
Methods
A study cohort of 100 patients (39 male, 61 female, age 64.8±15.8 years) underwent ventilation/perfusion single photon emission computed tomography (V/Q-SPECT/CT) to exclude acute PE on SPECT/CT OPTIMA NM/CT 640 (GE Healthcare). Two 3D lung lobe quantification software tools (Q. Lung: Xeleris 4.0, GE Healthcare and LLQ: Hermes Hybrid 3D Lung Lobar Quantification, Hermes Medical Solutions) were used to evaluate the numerical lobar ventilation/perfusion ratio (VQR) and lobar volume/perfusion ratio (VPR). A test of linearity and equivalence of the two 3D software tools was performed using Pearson, Spearman, quadratic weighted kappa and the mean squared deviation for VPR/VQR. An algorithm was developed that identified PE candidates using ROC analysis. The agreement between the PE findings of an experienced nuclear medicine expert and the calculated PE candidates was represented by the magnitude of the YOUDEN index (J) and the size of the area under the receiver operating curve (AUC).
Results
Both 3D software tools showed good comparability. The YOUDEN index for QLUNG(VPR/VQR)/LLQ(VPR/VQR) was in the range from 0.2 to 0.5. The mean AUC averaged over all lung lobes for QLUNG(VPR) was 0.66, CI95%: ±14.0%, for QLUNG(VQR) 0.66, CI95%: ±13.3%, for LLQ(VPR) 0.64, CI95%: ±14.7% and for LLQ(VQR) 0.65, CI95%: ±13.1%.
Conclusion
This study reveals that 3D software tools are feasible for numerical PE detection. The clinical decision can be supported by using a numerical algorithm based on ROC analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- GB Sicherheit und Compliance, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Nuclear Medicine, University Hospital Aachen, Aachen, Germany.
- Faculty of Electrical Engineering & Information Technology, University of Applied Sciences, Düsseldorf, Germany.
- Max-Planck-Institut für Eisenforschung GmbH, Düsseldorf, Germany.
- Nuclear Medicine, University Hospital Halle, Halle/Saale, Germany.
- Institute of Neuroscience and Medicine (INM-4), Forschungszentrum Jülich GmbH, Jülich, Germany.
Förderung
- GE Healthcare
Zitieren
APA
Vogt, J. K., Vogt, W. K., Heinzel, A., & Mottaghy, F. M. (2024). Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio. Nuklearmedizin - NuclearMedicine, 63(04), 259-266. https://doi.org/10.1055/a-2287-2051
Vancouver
Vogt JK, Vogt WK, Heinzel A, Mottaghy FM. Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio. Nuklearmedizin - NuclearMedicine. 2024;63(04):259-266. doi:10.1055/a-2287-2051
BibTeX
@article{Vogt2024,
author = {Vogt, Julia Katharina and Vogt, Wolfgang Kurt and Heinzel, Alexander and Mottaghy, Felix M},
title = {Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2024},
volume = {63},
number = {04},
pages = {259--266},
doi = {10.1055/a-2287-2051}
}
EUVIMED